메뉴 건너뛰기




Volumn 67, Issue 3, 2016, Pages 344-346

Effects of P-selectin antagonist inclacumab in patients undergoing coronary artery bypass graft surgery: SELECT-CABG trial

Author keywords

[No Author keywords available]

Indexed keywords

INCLACUMAB; PADGEM PROTEIN; PLACEBO; CARDIOVASCULAR AGENT; MONOCLONAL ANTIBODY;

EID: 84957824881     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.10.071     Document Type: Letter
Times cited : (35)

References (5)
  • 1
    • 84922062781 scopus 로고    scopus 로고
    • Saphenous vein graft failure after coronary artery bypass surgery: Insights from PREVENT IV
    • C.N. Hess, R.D. Lopes, C.M. Gibson, and et al. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV Circulation 130 2014 1445 1451
    • (2014) Circulation , vol.130 , pp. 1445-1451
    • Hess, C.N.1    Lopes, R.D.2    Gibson, C.M.3
  • 2
    • 3042622159 scopus 로고    scopus 로고
    • Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1
    • J.F. Tanguay, P. Geoffroy, M.G. Sirois, and et al. Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1 Thromb Haemost 91 2004 1186 1193
    • (2004) Thromb Haemost , vol.91 , pp. 1186-1193
    • Tanguay, J.F.1    Geoffroy, P.2    Sirois, M.G.3
  • 3
    • 0037769793 scopus 로고    scopus 로고
    • Platelet P-selectin facilitates atherosclerotic lesion development
    • P.C. Burger, and D.D. Wagner Platelet P-selectin facilitates atherosclerotic lesion development Blood 101 2003 2661 2666
    • (2003) Blood , vol.101 , pp. 2661-2666
    • Burger, P.C.1    Wagner, D.D.2
  • 4
    • 84877755222 scopus 로고    scopus 로고
    • Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab-preclinical and clinical studies
    • D. Kling, C. Stucki, S. Kronenberg, and et al. Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab-preclinical and clinical studies Thromb Res 131 2013 401 410
    • (2013) Thromb Res , vol.131 , pp. 401-410
    • Kling, D.1    Stucki, C.2    Kronenberg, S.3
  • 5
    • 84876779047 scopus 로고    scopus 로고
    • Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: Results of the SELECT-ACS trial
    • J.C. Tardif, J.F. Tanguay, S.S. Wright, and et al. Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial J Am Coll Cardiol 61 2013 2048 2055
    • (2013) J Am Coll Cardiol , vol.61 , pp. 2048-2055
    • Tardif, J.C.1    Tanguay, J.F.2    Wright, S.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.